期刊文献+

鞘内注射甲氨蝶呤、地塞米松治疗神经精神狼疮的随访研究

Follow of pulse therapy of methylprednisolone combinded with intrathecal methotrexate and dexamethasone on patiens with neuropsychiatric systemic lupus erythematosus
下载PDF
导出
摘要 目的观察两种方法治疗神经精神狼疮(NPSLE)的远期疗效,并探讨NPSLE复发的危险因素。方法36例NPSLE随机分成两组,两组均静脉冲击甲泼尼龙冲(MP)1g3d,实验组联合鞘内注射甲氨蝶呤(MTX)10mg和地塞米松(DXM)10mg每周1次,≤3次。对照组每周应用环磷酰胺(CTX)0.4g/1次,≤3次。观察两组1年内NPSLE的复发率和NPSLE复发时与未复发患者随访6个月和1年时系统性红斑狼疮活动指数(SLEDAI)△(不计神经精神评分)和泼尼龙维持量差异有无统计学意义。结果1年内实验组18例患者有2例复发,对照组16例有8例复发,实验组显著低于对照组。NPSLE复发时与未复发患者随访6个月、1年时系统性红斑狼疮活动指数(SLEDAI)和泼尼龙维持量差异无统计学意义。结论静脉冲击MP联合鞘内注射MTX和DXM治疗NPSLE复发率低;NPSLE复发与SLEDAI和泼尼龙维持量无关。 Objective To investigate long term outcome of pulse therapy of methylprednisolone(MP)combinded with intrathecal methotrexate(MTX)and dexamethasone(DXM)on patiens with neuro-psychiatric systemic lupus erythematosus(NPSLE)and risk factor of relapse of NPSLE.Methods 36 patients with NPSLE were randomly divided into 2 groups,2 groups were treated with pulse therapy of MP 1g for 3 days,one combinded with intrathecal(IT)MTX10 mg and(DXM)10 mg once a week,another combinded with intravenous cyclophosphamide(CTX)0.4 g per week,two ways were no more than 3 times.Results 2 of eighteen patiens in experimental groups and eight of sixteen patiens in control groups relapsed in one year.SLEDAI and dose of prednisone had no signifficent difference between patiens when they relapsed and patiens had not relapsed while they had been followed for six months and one year.Conclusion Patiens with NPSLE treated with pulse therapy of MP combinded with IT MTX and DXM has less relapse rate than that treated with pulse therapy of MP combinded with intravenous CTX.Relapse of NPSLE hase no related to SLEDAI and dose of prednisone.
出处 《中国实用医药》 2007年第24期7-9,共3页 China Practical Medicine
关键词 神经精神狼疮 甲泼尼龙 甲氨蝶呤 地塞米松 环磷酰胺 Neuropsychiatric systemic lupus erythematosus(NPSLE) Methylprednisolone Methotrexate Dexamethasone Cyclophosphamide
  • 相关文献

参考文献1

二级参考文献12

  • 1张奉春,董怡,赵玉华,林禾,姜泉,赵杰.系统性红斑狼疮中枢神经系统病变的诊断及治疗[J].北京医学,1994,16(5):277-280. 被引量:23
  • 2Hochberg MC.Updating the American Collage of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
  • 3ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.Arthritis Rheum,1999,42:599-608.
  • 4Bonbardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35:630-640.
  • 5Mok CC,Lau CS,Wong RWS.Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.J Rheumatol,2001,28:766-771.
  • 6Sanna G,Bertolaccini ML,Cuadrado MJ,et al.Neuropsychiatric manifestations in systemic lupus erythematosus:Prevalence and association with antiphospholipid antibodies.J Rheumatol,2003,30:985-992.
  • 7Valesini G,Priori R,Francia A,et al.Central nervous system involvement in systemic lupus erythematosus:a new therapeutic approach with intrathecal dexamethasone and methotremate.Springer Semin Immunopathol,1994,16:313-321.
  • 8Jennekens FG,Kater L.The central nervous system in systemic lupus erythematosus.Part 2.Pathogenetic mechanisms of clinical syndromes:a literature investigation.Rheumatology (Oxford),2002,41:619-630.
  • 9董怡,田新平,唐福林,赵岩,张奉春,张烜,曾小峰,张乃峥.鞘内联合注射甲氨蝶呤加地塞米松治疗狼疮中枢受累[J].中华风湿病学杂志,2001,5(4):220-222. 被引量:22
  • 10张莉芸,李小峰,王来远,魏华,王彩虹,王小霞.小剂量甲氨喋呤鞘内注射治疗系统性红斑狼疮中枢神经系统病变临床观察[J].山西临床医药,2002,11(6):436-437. 被引量:2

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部